JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, T. J.
Right arrow Articles by Hambleton, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, T. J.
Right arrow Articles by Hambleton, J.
Journal of the American Podiatric Medical Association Volume 91 Number 8 406-414 2001
Copyright © 2001 American Podiatric Medical Association

Hemophilic Arthropathy: Considerations in Management

Thomas J. Chang, DPM*, Shenin Mohamed, BSc(Pharm), DPM{dagger} and Julie Hambleton, MD{ddagger}

* Clinical Professor and Immediate Past Chairman, California College of Podiatric Medicine; private practice San Francisco and Santa Rosa, CA. Mailing address: 2281 Cleveland Ave, Santa Rosa, CA 95403.
{dagger} Submitted during second-year residency, Memorial Hospital of Rhode Island, Brown University, Pawtucket, RI.
{ddagger} Associate Clinical Professor, University of California, San Francisco School of Medicine, San Francisco, CA.

Abstract

The authors evaluate nonsurgical and surgical approaches to treating patients with hemophilic arthropathy and review the functional and economic limitations imposed on treating these patients. Indications for surgery are discussed and a case study that incorporates both conservative and surgical management options is presented. While the advent of factor replacement therapy has dramatically changed the course of treatment and prognosis for patients with hemophilia, the authors argue that the economic burden of treating these patients is still very high. The authors recommend that proper conservative and surgical management options for patients with hemophilia should be based upon a thorough understanding of the disease process. (J Am Podiatr Med Assoc 91(8): 406-414, 2001)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Podiatric Medical Association.